ZBH monthly performance report
Check ZBH's monthly returns, drawdown, and seasonality trends — updated every month.
ZBH monthly report
—
Key takeaways
- Zimmer Biomet (ZBH) closed September 2026 at $94.25, down 5.79% for the month and −5.67% over the trailing 12 months.
- Year-to-date, ZBH is +4.82%, underperforming the S&P 500 which has returned +11.83% YTD.
- The stock is trading +2.94% versus its 200-day moving average ($91.56), a bullish technical signal.
- Over the past three years, ZBH has underperformed the S&P 500 by −94.31%, with a relative strength index reading of 44.9.
- Win rate over the trailing 39 months stands at 41% — 16 positive months versus 23 negative months.
Zimmer Biomet ended September 2026 at $94.25, posting a monthly return of −5.79%. The S&P 500 returned −0.58% over the same window, leaving relative performance at −5.21%.
The current quarter stands at +9.48% (Q3 2026 (QTD)), while medium-term trend remains constructive: price is +2.94% versus the 200-day moving average ($91.56).
Year-to-date, ZBH is +4.82% against SPY +11.83%, a gap of −7.02%. The stock is currently −11.82% below its 52-week high, with maximum 3-year drawdown at −39.99%.
| Period | ZBH | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −2.61% | +1.13% | −3.75% |
| 1 Week | +1.96% | +0.63% | +1.33% |
| 1 Month | −5.79% | −0.58% | −5.21% |
| 3 Months | +8.13% | +1.64% | +6.50% |
| 6 Months | +1.02% | +15.15% | −14.13% |
| YTD | +4.82% | +11.83% | −7.02% |
| 12 Months | −5.67% | +15.69% | −21.36% |
| 3 Years | −22.31% | +72.00% | −94.31% |
| Rank | Month | Return |
|---|---|---|
| #1 | Aug 2025 | +15.77% |
| #2 | Feb 2026 | +13.06% |
| #3 | Nov 2023 | +11.40% |
| #4 | Jul 2026 | +9.11% |
| #5 | Mar 2025 | +8.49% |
| Rank | Month | Return |
|---|---|---|
| #1 | Aug 2023 | −13.77% |
| #2 | May 2025 | −10.56% |
| #3 | Apr 2025 | −8.95% |
| #4 | Apr 2024 | −8.86% |
| #5 | Apr 2026 | −8.84% |
| Quarter | Return |
|---|---|
| Q2 2025 | −19.41% |
| Q3 2025 | +7.99% |
| Q4 2025 | −8.71% |
| Q1 2026 | +0.56% |
| Q2 2026 | −4.79% |
| Q3 2026 (QTD) | +9.48% |
| Year | Return |
|---|---|
| 2023 | −4.55% |
| 2024 | −13.20% |
| 2025 | −14.87% |
| 2026 | +4.82% |
| Metric | Value |
|---|---|
| 52-Week High | $106.88 (2025-10-22) |
| 52-Week Low | $79.12 (2026-05-11) |
| Current Price | $94.25 |
| 200-Day Moving Average | $91.56 |
| Price vs 200DMA | +2.94% |
| 3-Year Maximum Drawdown | −39.99% (2026-05-11) |
| Current Drawdown from 52W High | −11.82% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 44.9 |
| 3-Year Excess Return vs S&P 500 | −94.31% |
| RS Peak | 100 (Sep 2023) |
| RS Trough | 39.1 (May 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was ZBH's return for this report period?
ZBH returned −5.79% in the latest monthly window ending 2026-09-17.
Has ZBH outperformed SPY year to date?
YTD ZBH: +4.82% vs SPY: +11.83%.
What is ZBH's 12-month return?
−5.67% over the trailing 12 months.
Is ZBH above or below its 200-day moving average?
Price is +2.94% versus 200DMA ($91.56).
What is the maximum drawdown in the 3-year window?
−39.99% on 2026-05-11.